MOLECULAR HEALTH GUIDE Logo (WIPO, 02.08.2017)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MOLECULAR HEALTH GUIDE wurde als Bildmarke am 02.08.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Linien, Bänder #Briefe, die eine besondere Form des Schreibens darstellen #Vertikale Linien oder Bänder #Buchstabenreihen in verschiedenen Dimensionen #Monogramme, die aus verschlungenen, überlappenden oder anderweitig kombinierten Buchstaben bestehen
| Markenform | Bildmarke |
| Aktenzeichen | 1388772 |
| Registernummer | 015471592 |
| Länder | 
|
| Basismarke |
Nr. 015471592,
29. Dezember 2016
|
| Anmeldedatum | 02. August 2017 |
| Ablaufdatum | 02. August 2027 |
Markeninhaber
Kurfürsten-Anlage 21
69115 Heidelberg
DE
69115 Heidelberg
DE
Markenvertreter
Lehel Carré Thierschplatz 6
80538 München
DE
Waren und Dienstleistungen
09
Downloadable computer databases containing information in
the fields of medicine, health care, genomics,
bioinformatics, pharmaceuticals, life sciences and/or
biotechnology; downloadable computer databases containing
medical and/ or health information or records about or
relating to humans; downloadable computer software for
accessing, organizing, indexing, ranking, integrating,
linking, referencing, synthesizing, interpreting and
analyzing information from databases in the fields of
medicine, health care, genomics, pharmaceuticals, life
sciences and/or biotechnology and/or databases containing
medical and/or health information or records about or
relating to humans; downloadable mobile applications for
mobile devices, such as e.g. smart phones and/or tablet
computers, for accessing, organizing, synthesizing,
indexing, ranking, integrating, linking, referencing,
interpreting and analyzing information from databases in the
fields of medicine, health care, genomics, bioinformatics,
pharmaceuticals, life sciences and/or biotechnology and/or
databases containing medical and/or health information or
records about or relating to humans; downloadable software
for generating reports of the results of the data analysis
and interpretation relating to a patient's genome or the
data generated from molecular tests based on the analysis of
genomes, in particular through the application of next
generation sequencing (NGS) methods
38
Providing access to searchable databases containing medical,
pharmaceutical, biological, clinical and genomic information
and/or medical and/or health information or records,
molecular test results and/or patient specific data about or
relating to humans for scientific research purposes;
providing access to computer software and/or algorithms for
use by physicians, clinicians and other healthcare
professionals, laboratory personnel, consultants, scientists
and other researchers for medical diagnostic and/or
treatment and/or drug safety research and/or drug or
pharmaceuticals or other treatment discovery, research and/
or development; providing access to software and/or
algorithms for retrieval, integration, correlation, analysis
and/ or interpretation of genomic data, sequencing data
and/or molecular data, diseases, biomarkers, drug protocols,
drug interactions, clinical profiles, medical and/or health
information, records or data, patient specific data,
molecular test results, and/or data from clinical studies;
providing access to computer software and/or algorithms for
use by physicians, clinicians and other healthcare
professionals, laboratory personnel, consultants, scientists
and other researchers for medical diagnostic and/or
treatment purposes; providing access to software and/or
algorithms for retrieval, integration, correlation, analysis
and/or interpretation of genomic, sequencing and/or
molecular data, diseases, biomarkers, drug protocols, drug
interactions, clinical profiles, and/or medical and/or
health information, records or data, and/or patient specific
data, molecular test results, data from clinical studies,
and/or scientific research for medical diagnostic and/ or
treatment purposes; providing access to databases containing
medical, pharmaceutical, biological, clinical, molecular,
sequencing and genomic information, disease information,
biomarker information and/or medical or health information
or records about or relating to humans and/or patient
specific data, molecular test results, and/or scientific
research for medical diagnostic and/or treatment purposes
42
Technological consulting and research services in the fields
of health care, medicine, life sciences, biotechnology,
pharmaceuticals, bioinformatics, genomics and/or
pharmaceuticals and pharmaceutical safety for scientific
research purposes; technological consulting and research
services for the retrieval, integration, correlation,
analysis and/or interpretation of genomic data, sequencing
data, and/or molecular data, disease, biomarkers, drug
protocols, drug interactions, clinical profiles, medical
and/or health information, records or data, patient specific
data, molecular test results, and/or data from clinical
studies; scientific research for medical diagnostic and/or
treatment research and/or drug or pharmaceuticals or other
treatment discovery, research and/or development purposes;
designing and/or developing and/or hosting of searchable
databases containing medical, pharmaceutical, biological,
clinical and genomic information and/or medical and/or
health information or records, molecular test results and/or
patient specific data about or relating to humans for
scientific research purposes; designing and/or developing
and/or providing temporary use of on-line non-downloadable
computer software and/or algorithms for use by physicians,
clinicians and other healthcare professionals, laboratory
personnel, consultants, scientists and other researchers for
medical diagnostic and/or treatment and/or drug safety
research and/or drug or pharmaceuticals or other treatment
discovery, research and/ or development; designing and/or
developing and/or providing temporary use of on-line
non-downloadable software and/or algorithms for retrieval,
integration, correlation, analysis and/or interpretation of
genomic data, sequencing data and/or molecular data,
diseases, biomarkers, drug protocols, drug interactions,
clinical profiles, medical and/or health information,
records or data, patient specific data, molecular test
results, and/or data from clinical studies; scientific
research for medical diagnostic and/or treatment research
and/or drug or pharmaceuticals or other treatment discovery,
research and/or development purposes; research or consulting
services featuring software under a software as a service
(SaaS) model for enabling the retrieval, integration,
correlation, analysis and/or interpretation of genomic,
sequencing and molecular data, disease information,
biomarker information, drug protocols, drug interactions,
clinical profiles, patient specific data, molecular test
results, and/or data from clinical studies; scientific
research and/or providing health and/or medical research
information for medical, diagnostic and/or treatment and/or
drug safety research and/or drug or pharmaceuticals or other
treatment discovery, research and/or development purposes;
online provision of non-downloadable web-based applications
for mobile devices, such as e.g. smart phones and tablets,
and web applications accessible through the Internet in the
fields of medicine, health care, genomics, bioinformatics,
pharmaceuticals and pharmaceutical safety, life sciences and
biotechnology; data automation and collection services using
proprietary software to evaluate, analyze and collect
service data for scientific research purposes in the fields
of genomics, health care, pharmaceuticals, life sciences,
bioinformatics, biotechnology and medicine; providing
results in the fields of the technical data analysis and
interpretation relating to a patient's genome or the data
generated from molecular tests based on the analysis of
genomes, in particular through the application of next
generation sequencing (NGS) methods, including, e.g. in the
form of a report; research services for the retrieval,
integration, correlation, analysis and/or interpretation of
genomic, sequencing and/or molecular data, diseases,
biomarkers, drug protocols, drug interactions, clinical
profiles, and/or medical and/or health information, records
or data, and/or patient specific data, molecular test
results, data from clinical studies, and/or scientific
research for medical diagnostic and/or treatment purposes;
providing temporary use of on-line non-downloadable computer
software and/or algorithms for use by physicians, clinicians
and other healthcare professionals, laboratory personnel,
consultants, scientists and other researchers for medical
diagnostic and/or treatment purposes; providing temporary
use of on-line non-downloadable software and/or algorithms
for retrieval, integration, correlation, analysis and/or
interpretation of genomic, sequencing and/or molecular data,
diseases, biomarkers, drug protocols, drug interactions,
clinical profiles, and/or medical and/or health information,
records or data, and/or patient specific data, molecular
test results, data from clinical studies, and/or scientific
research for medical diagnostic and/ or treatment purposes;
providing research information in the fields of life
sciences, biotechnology, bioinformatics
44
Medical consulting services for the retrieval, integration,
correlation, analysis and/or interpretation of genomic,
sequencing and/or molecular data, diseases, biomarkers, drug
protocols, drug interactions, clinical profiles, and/or
medical and/or health information, records or data, and/or
patient specific data, molecular test results, data from
clinical studies, and/or scientific research for medical
diagnostic and/or treatment purposes; providing medical
information from computer databases containing medical,
pharmaceutical, biological, clinical, molecular, sequencing
and genomic information, disease information, biomarker
information and/or medical or health information or records
about or relating to humans and/or patient specific data,
molecular test results, and/or scientific research for
medical diagnostic and/or treatment purposes; medical
consulting services in the fields of health, medical care,
biotechnology, bioinformatics, life sciences,
pharmaceuticals and medicine; providing information in the
fields of health, healthcare, pharmaceuticals and
pharmaceutical safety, genetic testing for medical purposes;
medical consulting services with respect to the treatment
and diagnosis of individuals; providing pharmaceutical
information, including information about drug safety and/or
drug compatibility in relation to therapy and the treatment
of individuals; medical consulting services in the fields of
diagnostics and patient treatment and treatment protocols;
providing medical information and results relating to a
patient's genome or the data generated from molecular tests
based on the analysis of genomes, in particular through the
application of next generation sequencing (NGS) methods,
including, e.g. in the form of a report, to physicians,
clinicians and other healthcare professionals, laboratory
personnel, consultants, scientists and other researchers for
medical diagnostic and/ or treatment purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 15. Februar 2022 | 2022/10 Gaz | CN | RAW: Rule 18ter(4) protected goods and services |
| 21. Oktober 2021 | 2021/46 Gaz | CN | RAW: Rule 18ter(4) protected goods and services |
| 01. Oktober 2019 | 2019/40 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 28. März 2019 | 2019/14 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 20. März 2019 | 2019/19 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 11. Dezember 2018 | 2018/50 Gaz | KR | Ablehnung |
| 23. November 2018 | 2018/48 Gaz | CN | Ablehnung |
| 04. Oktober 2018 | 2018/40 Gaz | JP | Ablehnung |
| 22. Mai 2018 | 2018/22 Gaz | SG | Ablehnung |
| 05. März 2018 | 2018/11 Gaz | IN | Ablehnung |
| 02. August 2017 | 2018/5 Gaz | EM | Eintragung |
ID: 141388772